Company Search:
Advanced Search
Sponsored Links
Choong Ang Vaccine Laboratory Company Snapshot
Choong Ang Vaccine Laboratory operates within the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Choong Ang Vaccine Laboratory with three other companies in this sector in South Korea: Komipharm International Company Limited (2018 sales of 34.99 billion Korean Won [US$29.43 million] of which 96% was Finished Goods), Eu Biologics Co Ltd (24.89 billion Korean Won [US$20.93 million] of which 91% was OCV), and Corestem Inc (22.32 billion Korean Won [US$18.77 million] of which 87% was The clinical trial agent).

Sales Analysis. During the year ended December of 2018, sales at Choong Ang Vaccine Laboratory were 33.15 billion Korean Won (US$27.88 million). This is an increase of 4.0% versus 2017, when the company's sales were 31.87 billion Korean Won. Despite this increase, sales are still below the level achieved in 2016, when Choong Ang Vaccine Laboratory reported sales of 37.90 billion Korean Won.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Choong Ang Vaccine Laboratory
  Stock Performance Chart for Choong Ang Vaccine Laboratory
  Stock Data: Recent Stock Performance:
  Current Price (12/6/2019): 17,300
(Figures in Korean Won)
1 Week -0.3%   13 Weeks -8.5%  
4 Weeks -10.8%   52 Weeks -6.0%  
Choong Ang Vaccine Laboratory Key Data:
  Ticker: 072020 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2018 Sales 33,152,986,676
(Year Ending Jan 2019).
Employees: 165
  Currency: Korean Won Market Cap: 172,285,285,100
  Fiscal Yr Ends: December Shares Outstanding: 9,958,687
  Share Type: Common Closely Held Shares: 3,636,946
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.